Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098 AM3)
This study has been completed.
Study NCT00820027   Information provided by Merck

First Received on January 7, 2009.   Last Updated on May 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain, Postoperative
More general conditions related to this trial
Pain
Pathologic Processes
Postoperative Complications
Signs and Symptoms
Interventions listed in this trial
Etoricoxib 90 mg
Etoricoxib 120 mg
Ibuprofen 600 mg
Matching Placebo for Ibuprofen
Additional drug interventions recognized in this trial
Etoricoxib
Ibuprofen
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services